MENU
+Compare
PULM
Stock ticker: NASDAQ
AS OF
Jan 22 closing price
Price
$6.11
Change
+$0.13 (+2.17%)
Capitalization
22.32M

PULM Pulmatrix Forecast, Technical & Fundamental Analysis

a developer of pharmaceuticals for pulmonary disease

Industry Biotechnology
PULM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for PULM with price predictions
Jan 08, 2025

PULM's Stochastic Oscillator descending into oversold zone

The Stochastic Oscillator for PULM moved into oversold territory on January 08, 2025. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 24, 2024. You may want to consider a long position or call options on PULM as a result. In of 104 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where PULM advanced for three days, in of 223 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 75 cases where PULM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for PULM moved out of overbought territory on January 03, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 21 similar instances where the indicator moved out of overbought territory. In of the 21 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for PULM turned negative on January 06, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PULM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PULM broke above its upper Bollinger Band on December 27, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.044) is normal, around the industry mean (15.076). P/E Ratio (0.000) is within average values for comparable stocks, (88.202). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.833). PULM has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (2.231) is also within normal values, averaging (264.879).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PULM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PULM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
PULM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

a developer of pharmaceuticals for pulmonary disease

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
36 Crosby Drive
Phone
+1 781 357-2333
Employees
22
Web
https://www.pulmatrix.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NVST21.050.50
+2.43%
Envista Holdings Corp
FNV129.90-0.76
-0.58%
Franco-Nevada Corp
PRLB39.86-0.24
-0.60%
Proto Labs
MHLD1.10-0.04
-3.51%
Maiden Holdings Ltd
APCX0.43-0.04
-8.90%
AppTech Payments Corp

PULM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PULM has been loosely correlated with ORMP. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if PULM jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PULM
1D Price
Change %
PULM100%
+2.17%
ORMP - PULM
33%
Loosely correlated
+0.43%
INM - PULM
30%
Poorly correlated
-20.79%
GERN - PULM
27%
Poorly correlated
+1.01%
TSHA - PULM
26%
Poorly correlated
N/A
PMVP - PULM
25%
Poorly correlated
-2.22%
More